Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents
{{output}}
Objectives: To discuss (1) recent and emerging data for pharmacological management of untreated and relapsed/refractory (R/R) mantle cell lymphoma (MCL) with agents approved in the United States, (2) important considerations for toxicity monitoring and managem... ...
